• Pause Video Play Video

    • A World Leading SFI Research Centre

    The Irish Centre for Fetal and Neonatal Translational Research (INFANT) is Ireland’s first dedicated perinatal research centre.

    Mission and Values

    Our mission is to make pregnancy safer and to improve health outcomes for mothers and babies. We are developing innovative technologies to improve the treatment and care available to mothers and babies worldwide.

    Our Partnerships

    INFANT is funded by Science Foundation Ireland. We are an industry-facing centre developing innovations that build commercial opportunities with our industry partners.

    Who We Are

    A World Leading Science Foundation Ireland Research Centre

    INFANT is a global force for development in perinatal healthcare, funded by Science Foundation Ireland.

    Although maternal and perinatal complications account for nearly 10% of the global burden of disease, R&D investment in perinatal health remains small and non-strategic. It has been estimated that equitable industry R&D and public sector research funding in perinatal health over the next 10-20 years could avert 3% of the global disease burden.

    Access to world-first technologies allows our industry partners to deliver innovative solutions to global markets, creating exciting and vast economic opportunities. Most importantly of all, INFANT will have fundamental societal impacts by changing the delivery of healthcare and improving outcomes for the most vulnerable members of our society – mothers and their babies.

    Our Research

    Latest Publications

    View All

    • Skin Microbiome Prior to Development of Atopic Dermatitis: Early Colonization with Commensal Staphylococci at 2 months is Associated with a Lower Risk of Atopic Dermatitis at 1 year

      Kennedy EA, Connolly J, Hourihane JO’B, Fallon PG, McLean WHI, Murray D, Jo J-H, Segre JA, Kong HH, Irvine AD.

    • Experience of miscarriage: an interpretative phenomenological analysis

      Meaney, S., Corcoran, P., Spillane, N. and O'Donoghue, K.

    • Exposure to Hypertensive Disorders of Pregnancy Increases the Risk of Autism Spectrum Disorder in Affected Offspring

      Curran, E.A., O’Keeffe, G.W., Looney, A.M., Moloney, G., Hegarty, S.V., Murray, D.M., Khashan, A.S. and Kenny, L.C.

    Our News

    All News
    • Paediatric doctor family
      21 May 2018

      INFANT Secures Almost €1Million to Enable Better Clinical Trials for Infants and Children

      Launch of ‘In4Kids’ - a new Irish paediatric trial network to support research developing new medicines for children

    • Gillian Maher
      19 Mar 2019

      INFANT PhD Student wins Pfizer‐SRI President’s Presenter’s Award

    • Keelin
      06 Mar 2019

      INFANT PI leads National Bereavement Standards in Maternity Services

      Bereavement Forum brings together national and international experts

    • Alison photoshoot
      04 Mar 2019

      INFANT celebrates Engineers Week 2019

      Meet our team of engineers!

    • famelab
      01 Mar 2019

      INFANT takes to the stage at FameLab Cork

      15 researchers from a range of disciplines participated in the Cork heat

    Upcoming Events

    Who We Are

    Get to know our international community of researchers, the multi-disciplinary team who implement our research programme across pregnancy, birth, infancy and childhood health.

    Our vision is to establish INFANT as the world’s leading perinatal translational research centre. The centre is led Prof Geraldine Boylan. A team of researchers and postgraduates drive the INFANT programme, underpinned by a dedicated and highly skilled research support team and operations team.

    Our Team
    1 Directors
    12 Principal Investigators
    16 Postgraduate Students
    13 Operations Team
    Alumni
    National and International Partners
    Mum and sleeping baby

    Get Involved

    INFANT brings people of all ages and interests together.
    Engage with our research team through our Events and Outreach Programmes.

    Outreach Programme

    Subscribe to our newsletter